Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • Dow

    39,760.08
    +477.75 (+1.22%)
     
  • Nasdaq

    16,399.52
    +83.82 (+0.51%)
     
  • Bitcoin USD

    70,573.87
    +576.49 (+0.82%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,972.32
    +40.34 (+0.51%)
     
  • Gold

    2,217.80
    +5.10 (+0.23%)
     
  • Crude Oil

    81.90
    +0.55 (+0.68%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

J&J fourth-quarter sales up 1.7 percent, plans to divest diabetes care division

FILE PHOTO -- Bottles of Johnson & Johnson baby lotion line a drugstore shelf in New York October 15, 2015. REUTERS/Lucas Jackson/File Photo

(Reuters) - Johnson & Johnson reported a 1.7 percent rise in fourth-quarter sales, due to a strong demand for its newer products.

The diversified healthcare company's sales rose to $18.11 billion in the fourth quarter from $17.81 billion a year earlier.

Net earnings rose to $3.81 billion, or $1.38 per share, from $3.22 billion, or $1.15 per share.

The band-aid maker also said on Tuesday that it was looking to divest its diabetes care division.

(Reporting by Natalie Grover in Bengaluru; Editing by Savio D'Souza)